These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide. Tugarinov V; Zvi A; Levy R; Anglister J Nat Struct Biol; 1999 Apr; 6(4):331-5. PubMed ID: 10201400 [TBL] [Abstract][Full Text] [Related]
24. Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135. Huang X; Barchi JJ; Lung FD; Roller PP; Nara PL; Muschik J; Garrity RR Biochemistry; 1997 Sep; 36(36):10846-56. PubMed ID: 9312273 [TBL] [Abstract][Full Text] [Related]
25. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516 [TBL] [Abstract][Full Text] [Related]
26. Epitope mapping antibody-antigen complexes by nuclear magnetic resonance spectroscopy. Kustanovich I; Zvi A Methods Mol Biol; 1996; 66():25-37. PubMed ID: 8959701 [No Abstract] [Full Text] [Related]
27. Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations. Kanyalkar M; Srivastava S; Saran A; Coutinho E J Pept Sci; 2004 Jun; 10(6):363-80. PubMed ID: 15214441 [TBL] [Abstract][Full Text] [Related]
28. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection. Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041 [TBL] [Abstract][Full Text] [Related]
29. Global and local structural properties of the principal neutralizing determinant of the HIV-1 envelope protein gp120. Andrianov AM J Biomol Struct Dyn; 1999 Feb; 16(4):931-53. PubMed ID: 10217460 [TBL] [Abstract][Full Text] [Related]
30. NMR mapping of the antigenic determinant recognized by an anti-gp120, human immunodeficiency virus neutralizing antibody. Zvi A; Kustanovich I; Feigelson D; Levy R; Eisenstein M; Matsushita S; Richalet-Sécordel P; Regenmortel MH; Anglister J Eur J Biochem; 1995 Apr; 229(1):178-87. PubMed ID: 7538073 [TBL] [Abstract][Full Text] [Related]
31. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls. Sitz KV; Ratto-Kim S; Hodgkins AS; Robb ML; Birx DL J Infect Dis; 1999 Apr; 179(4):817-24. PubMed ID: 10068576 [TBL] [Abstract][Full Text] [Related]
32. Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes. Chang SY; Vithayasai V; Vithayasai P; Essex M; Lee TH J Infect Dis; 2000 Aug; 182(2):442-50. PubMed ID: 10915074 [TBL] [Abstract][Full Text] [Related]
33. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera. Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152 [TBL] [Abstract][Full Text] [Related]
34. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization. Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063 [TBL] [Abstract][Full Text] [Related]
36. [Theoretical conformational NMR-analysis of RP342 peptide, affiliated with the immunogenic fragment of HIV-1 gp120 protein]. Andrianov AM Dokl Akad Nauk; 1995 Oct; 344(4):546-8. PubMed ID: 8590869 [No Abstract] [Full Text] [Related]
37. Evaluation of a synthetic vaccine construct as antigen for the detection of HIV-induced humoral responses. Hewer R; Meyer D Vaccine; 2005 Mar; 23(17-18):2164-7. PubMed ID: 15755588 [TBL] [Abstract][Full Text] [Related]
38. [Model of three dimensional structure of the immunodominant epitope of gp120 HIV(Thailand)]. Andrianov AM; Sokolov IuA Biofizika; 2003; 48(4):628-34. PubMed ID: 14515480 [TBL] [Abstract][Full Text] [Related]
39. [A spatial structure model of the basic antigenic determinant of the human immunodeficiency virus type 1 gp120 protein]. Andrianov AM; Akhrem AA Dokl Akad Nauk; 1995 Jun; 342(4):543-5. PubMed ID: 7580959 [No Abstract] [Full Text] [Related]
40. Immunogenicity of the GPGRAFY epitope on synthetic peptides. Chen YH; Yu T; Bai Y; Dierich MP Immunol Lett; 1999 Sep; 69(3):353-4. PubMed ID: 10528800 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]